LifeTech Scientific

LifeTech Scientific CapEx/D&A

The CapEx to Depreciation Ratio of LifeTech Scientific (1302.HK) as of Oct 23, 2026 is 22.27. In the previous year, CapEx to Depreciation Ratio was 26.03 — a change of -14.46% (lower).

CapEx/D&A

22.27

YoY

-14.46%

Last updated:

CapEx to Depreciation Ratio of LifeTech Scientific is 2024 22.27 . CapEx to Depreciation Ratio of LifeTech Scientific was 2023 26.03 . It decreases by -14.46% lower compared to the previous year.

The LifeTech Scientific CapEx/D&A history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/D&A
Date
CapEx/D&A
Jan 1, 2019
29.85 CNY
Jan 1, 2020
29.60 CNY
Jan 1, 2021
47.08 CNY
Jan 1, 2022
31.48 CNY
Jan 1, 2023
26.03 CNY
Jan 1, 2024
22.27 CNY
The LifeTech Scientific CapEx/D&A history
YEARCapEx/D&AYoY
22.27-14.46%
26.03-17.30%
31.48-33.15%
47.08+59.09%
29.60-0.86%
29.85—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

LifeTech Scientific Stock analysis

What does LifeTech Scientific do? LifeTech Scientific Corp is a leading company in the field of medical technology. The company was founded in 1999 in Beijing, China and has since become a global provider of medical products and solutions. LifeTech Scientific Corp has offices in the USA, Europe, Asia, and Africa and is listed on the Hong Kong Stock Exchange. The business model of LifeTech Scientific Corp is based on innovative medical solutions and products for cardiology and other medical specialties. The company aims to improve treatment options for patients and equip doctors with the best tools and technologies to provide the best diagnosis and treatment options. LifeTech Scientific Corp offers a wide range of products and solutions including diagnostic devices, implantable devices, surgical devices, and accessories. These products can be used in various medical specialties such as cardiology, vascular surgery, neurology, and intensive care. Cardiology is one of the key areas of LifeTech Scientific Corp. The company offers a wide range of products focused on treating heart conditions such as coronary artery disease, heart failure, and arrhythmias. This includes implantable cardiac devices such as Implantable Cardiac Defibrillators (ICDs) and pacemakers used to treat rhythm disorders. LifeTech Scientific Corp's devices are very advanced and provide patients with an excellent quality of life. In addition to cardiology, LifeTech Scientific Corp also offers devices and solutions for other medical specialties. In the field of neurology, for example, the company provides devices for monitoring brain activity and treating epilepsy. In vascular surgery, LifeTech Scientific Corp offers devices for diagnosing and treating aneurysms and narrowing of blood vessels. In intensive care, the company provides devices for ventilation and patient monitoring. The history of LifeTech Scientific Corp is characterized by continuous growth and the development of new products and solutions. In recent years, the company has built strategic partnerships with leading medical institutions and research facilities around the world to advance the development of new technologies and products. Overall, LifeTech Scientific Corp is now one of the leading companies in the field of medical technology, offering innovative solutions for a range of medical specialties. The company is committed to improving patients' quality of life and providing doctors with the best tools and technologies to ensure the best possible treatment. LifeTech Scientific is one of the most popular companies on Eulerpool.

Frequently Asked Questions about LifeTech Scientific stock

CapEx to Depreciation Ratio of LifeTech Scientific is 22.27 in 2024.

CapEx to Depreciation Ratio of LifeTech Scientific changed from 26.03 to 22.27, representing a -14.46% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of CapEx to Depreciation Ratio LifeTech Scientific since 2006 – with annual values, charts, and detailed analysis.

The CapEx/D&A ratio compares investment spending to asset depreciation. Ratios above 1.0x indicate the company is growing its asset base, below 1.0x suggests underinvestment.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Depreciation Ratio's LifeTech Scientific with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Depreciation Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Depreciation Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — LifeTech Scientific

All Key Metrics — LifeTech Scientific